Compounds > topotecan
Page last updated: 2024-08-24

topotecan and Chronic Illness

topotecan has been researched along with Chronic Illness in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Ebinger, M; Fuchs, J; Heinz, AT; Klingebiel, T; Koscielniak, E; Kratz, CP; Ljungman, G; Münter, MW; Pajtler, KW; Rößler, J; Schönstein, A; Seitz, G; Sparber-Sauer, M; Stegmaier, S; Timmermann, B; Vokuhl, C; von Kalle, T1
Badel, JN; Bogart, E; Corradini, N; Cougnenc, O; Courbon, F; Defachelles, AS; Deley, MCL; Gambart, M; Giraudet, AL; Kolesnikov-Gauthier, H; Oudoux, A; Rault, E; Schleiermacher, G; Sevrin, F; Valteau-Couanet, D1
Carta, R; Cefalo, MG; D'Andrea, ML; De Ioris, MA; Del Baldo, G; Del Bufalo, F; Fabozzi, F; Garganese, MC; Giovannoni, I; Greco, AM; Locatelli, F; Mastronuzzi, A; Stracuzzi, A; Tangari, F; Villani, MF1
Belinson, JL; Michener, CM1
Crumpacker, CS; Dezube, BJ; Li, CJ; Pardee, AB; Zhang, LJ1

Trials

1 trial(s) available for topotecan and Chronic Illness

ArticleYear
Phase II study of
    Pediatric blood & cancer, 2023, Volume: 70, Issue:11

    Topics: 3-Iodobenzylguanidine; Adolescent; Busulfan; Child; Child, Preschool; Chronic Disease; Humans; Melphalan; Neoplasm Recurrence, Local; Neuroblastoma; Topotecan; Young Adult

2023

Other Studies

5 other study(ies) available for topotecan and Chronic Illness

ArticleYear
Second-line treatment of pediatric patients with relapsed rhabdomyosarcoma adapted to initial risk stratification: Data of the European Soft Tissue Sarcoma Registry (SoTiSaR).
    Pediatric blood & cancer, 2023, Volume: 70, Issue:7

    Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Chronic Disease; Cyclophosphamide; Etoposide; Humans; Polyketides; Recurrence; Retrospective Studies; Rhabdomyosarcoma; Sarcoma; Soft Tissue Neoplasms; Topotecan

2023
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series.
    Scientific reports, 2023, 11-07, Volume: 13, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Child; Chronic Disease; Cyclophosphamide; Humans; Mice; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; Topotecan

2023
Modern management of recurrent ovarian carcinoma. A systematic approach to a chronic disease.
    Oncology (Williston Park, N.Y.), 2005, Volume: 19, Issue:10

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chronic Disease; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Salvage Therapy; Secondary Prevention; Topotecan

2005
Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Mar-01, Volume: 90, Issue:5

    Topics: Acute Disease; Antiviral Agents; Camptothecin; Cells, Cultured; Chronic Disease; Curcumin; Gene Expression Regulation, Viral; HIV Infections; HIV Long Terminal Repeat; HIV-1; In Vitro Techniques; Naphthoquinones; RNA, Viral; Topotecan; Virus Replication

1993
Recurrent ovarian cancer as chronic disease.
    Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Chronic Disease; Deoxycytidine; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Gemcitabine; Humans; Ovarian Neoplasms; Recurrence; Topotecan; Trastuzumab

2002